logo

For the Inventor, By the Inventor

Bruck an der Leitha, Austria

Franz Rovenszky

This inventor holds 11 USPTO granted patents. Top assignees: Chemisch Pharmazeutische Forschungsgesellschaft M.b.h., Chemie Linz Aktiengesellschaft, Cl Pharma Aktiengesellschaft. Active years: 1986-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz Rovenszky. Retrieved from https://idiyas.com/inventor/franz-rovenszky-klayix77

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Bruck a.d.Leitha, AT (1988 - 1990)
  • Bruck an der Leitha, AT (1986 - 1992)

Company Filing History:

goldMedal3 out of 6 
 
Chemisch Pharmazeutische Forschungsgesellschaft M.b.h.
 patents
silverMedal2 out of 76 
 
Chemie Linz Aktiengesellschaft
 patents
bronzeMedal2 out of 11 
 
Cl Pharma Aktiengesellschaft
 patents
4. 1 out of 1 
 
Chemi Linz Aktiengesellschaft
 patent
5. 1 out of 1 
 
Chemie Linz Akteingesellschaft
 patent
6. 1 out of 1 
 
Ebewe Arzneimittel Gesellschaft M.b.h.
 patent
7. 1 out of 4 
 
Laevosan-Gesellschaft Mbh & Co Kg
 patents

Years Active: 1986-1992

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5100911 - Thienyloxyalkylamine derivatives, process for their preparation and (1992-03-31),
2. 5086180 - Sulphamoylthiophenes, a process for their preparation (1992-02-04),
3. 5077307 - Thienopyran derivatives, their use for treating hypertension and asthma (1991-12-31),
4. 4978671 - Thieno (3',4'-4,5)imidazo(2,1-b)thiazole derivatives, a process for (1990-12-18),
5. 4927821 - Enol ethers of (1990-05-22),
6. 4841065 - Isoxazole derivatives with antiviral activities and pharmaceutical (1989-06-20),
7. 4818760 - Derivatives of pyridylsulfinyl(benz-or thieno-)imidazoles and their use (1989-04-04),
8. 4812472 - Isoxazole compounds and pharmaceutical compositions containing them for (1989-03-14),
9. 4778803 - Nitrogen-arylmethoxy-thiophene derivatives and acid addition salts (1988-10-18),
10. 4720501 - 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and salts thereof (1988-01-19),
11. 4596830 - Novel derivatives of 2-(2-thienyl)-imidazo[4,5-b]-pyridines and their (1986-06-24),

Title: Franz Rovenszky: Innovator in Pharmaceutical Chemistry

Introduction

Franz Rovenszky is a notable inventor based in Bruck an der Leitha, Austria. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 11 patents. His work focuses on the development of novel chemical compounds with potential therapeutic applications.

Latest Patents

Among his latest patents are "Thienyloxyalkylamine derivatives, process for their preparation" and "Sulphamoylthiophenes, a process for their preparation." Additionally, he has worked on "Sulphamoylathiophenes of the formula ##STR1## in which Y denotes O or S." These innovations reflect his expertise in creating complex chemical structures that may lead to new medicinal products.

Career Highlights

Franz Rovenszky has had a distinguished career, working with prominent companies such as Chemisch Pharmazeutische Forschungsgesellschaft M.b.h. and Chemie Linz Aktiengesellschaft. His experience in these organizations has allowed him to refine his skills and contribute to various research projects in the pharmaceutical sector.

Collaborations

Throughout his career, Rovenszky has collaborated with esteemed colleagues, including Dieter Binder and Hubert P Ferber. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Franz Rovenszky's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of new chemical compounds with potential therapeutic benefits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…